[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global and North America Peripheral Arterial Disease (PAD) Drugs Market Status and Future Forecast 2013-2023

September 2018 | 106 pages | ID: GD5CEBE13A4EN
99Strategy

US$ 2,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Key Content of Chapters (Including and can be customized)

Part 1: Market Overview, Development, and Segment by Type, Application & Region
Part 2: Global Market by company, Type, Application & Region
Part 3: North America Market by company, Type, Application & Region
Part 4-6: Key Regions of North America Market by Type, Application
Part 7: Company information, Sales, Cost, Margin etc.
Part 8: Conclusion

Market Segment as follows:

By Region
  • Global (North America, Europe, Asia etc.)
  • North America (United States, Canada, Mexico)
Key Companies
  • AstraZeneca Plc. (UK)
  • Bayer HealthCare Pharmaceuticals (Germany)
  • Bristol-Myers Squibb Company (US)
  • Merck & Co., Inc. (US)
  • Proteon Therapeutics, Inc. (US)
  • Sanofi S.A. (France)
  • Symic Bio, Inc. (US)
  • TheraVasc Inc. (US)
Market by Type
  • Clopidogrel (Plavix)
  • Prasugrel (Effient)
  • Ticagrelor (Brilinta)
  • Vorapaxar (Zontivity)
  • Others
Market by Application
  • Hospitals
  • Clinics
  • Others
PART 1 MARKET OVERVIEW

1.1 Market Definition
1.2 Market Development
1.3 By Type
1.4 By Application
1.5 By Region

PART 2 GLOBAL MARKET STATUS AND FUTURE FORECAST

2.1 Global Market by Region
2.2 Global Market by Company
2.3 Global Market by Type
2.4 Global Market by Application
2.5 Global Market by Forecast

PART 3 NORTH AMERICA MARKET STATUS AND FUTURE FORECAST

3.1 North America Market by Region
3.2 North America Market by Company
3.3 North America Market by Type
3.4 North America Market by Application
3.5 North America Market by Forecast

PART 4 UNITED STATES MARKET STATUS AND FUTURE FORECAST

4.1 United States Market by Type
4.2 United States Market by Application
4.3 United States Market by Forecast

PART 5 CANADA MARKET STATUS AND FUTURE FORECAST

5.1 Canada Market by Type
5.2 Canada Market by Application
5.3 Canada Market by Forecast

PART 6 MEXICO MARKET STATUS AND FUTURE FORECAST

6.1 Mexico Market by Type
6.2 Mexico Market by Application
6.3 Mexico Market by Forecast

PART 7 KEY COMPANIES

7.1 AstraZeneca Plc. (UK)
7.2 Bayer HealthCare Pharmaceuticals (Germany)
7.3 Bristol-Myers Squibb Company (US)
7.4 Merck & Co., Inc. (US)
7.5 Proteon Therapeutics, Inc. (US)
7.6 Sanofi S.A. (France)
7.7 Symic Bio, Inc. (US)
7.8 TheraVasc Inc. (US)

PART 8 CONCLUSION

LIST OF TABLES

Table Type of Peripheral Arterial Disease (PAD) Drugs
Table Application of Peripheral Arterial Disease (PAD) Drugs
Table Global Peripheral Arterial Disease (PAD) Drugs Market by Region, 2013-2017 (Million USD)
Table Global Peripheral Arterial Disease (PAD) Drugs Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table Global Peripheral Arterial Disease (PAD) Drugs Market by Company, 2013-2017 (Million USD)
Table Global Peripheral Arterial Disease (PAD) Drugs Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table Global Peripheral Arterial Disease (PAD) Drugs Market by Type, 2013-2017 (Million USD)
Table Global Peripheral Arterial Disease (PAD) Drugs Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Global Peripheral Arterial Disease (PAD) Drugs Market by Application, 2013-2017 (Million USD)
Table Global Peripheral Arterial Disease (PAD) Drugs Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table North America Peripheral Arterial Disease (PAD) Drugs Market by Region, 2013-2017 (Million USD)
Table North America Peripheral Arterial Disease (PAD) Drugs Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table North America Peripheral Arterial Disease (PAD) Drugs Market by Company, 2013-2017 (Million USD)
Table North America Peripheral Arterial Disease (PAD) Drugs Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table North America Peripheral Arterial Disease (PAD) Drugs Market by Type, 2013-2017 (Million USD)
Table North America Peripheral Arterial Disease (PAD) Drugs Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table North America Peripheral Arterial Disease (PAD) Drugs Market by Application, 2013-2017 (Million USD)
Table North America Peripheral Arterial Disease (PAD) Drugs Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table United States Peripheral Arterial Disease (PAD) Drugs Market by Type, 2013-2017 (Million USD)
Table United States Peripheral Arterial Disease (PAD) Drugs Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table United States Peripheral Arterial Disease (PAD) Drugs Market by Application, 2013-2017 (Million USD)
Table United States Peripheral Arterial Disease (PAD) Drugs Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Canada Peripheral Arterial Disease (PAD) Drugs Market by Type, 2013-2017 (Million USD)
Table Canada Peripheral Arterial Disease (PAD) Drugs Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Canada Peripheral Arterial Disease (PAD) Drugs Market by Application, 2013-2017 (Million USD)
Table Canada Peripheral Arterial Disease (PAD) Drugs Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Mexico Peripheral Arterial Disease (PAD) Drugs Market by Type, 2013-2017 (Million USD)
Table Mexico Peripheral Arterial Disease (PAD) Drugs Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Mexico Peripheral Arterial Disease (PAD) Drugs Market by Application, 2013-2017 (Million USD)
Table Mexico Peripheral Arterial Disease (PAD) Drugs Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table AstraZeneca Plc. (UK) Information
Table Peripheral Arterial Disease (PAD) Drugs Sales, Cost, Margin of AstraZeneca Plc. (UK)
Table Bayer HealthCare Pharmaceuticals (Germany) Information
Table Peripheral Arterial Disease (PAD) Drugs Sales, Cost, Margin of Bayer HealthCare Pharmaceuticals (Germany)
Table Bristol-Myers Squibb Company (US) Information
Table Peripheral Arterial Disease (PAD) Drugs Sales, Cost, Margin of Bristol-Myers Squibb Company (US)
Table Merck & Co., Inc. (US) Information
Table Peripheral Arterial Disease (PAD) Drugs Sales, Cost, Margin of Merck & Co., Inc. (US)
Table Proteon Therapeutics, Inc. (US) Information
Table Peripheral Arterial Disease (PAD) Drugs Sales, Cost, Margin of Proteon Therapeutics, Inc. (US)
Table Sanofi S.A. (France) Information
Table Peripheral Arterial Disease (PAD) Drugs Sales, Cost, Margin of Sanofi S.A. (France)
Table Symic Bio, Inc. (US) Information
Table Peripheral Arterial Disease (PAD) Drugs Sales, Cost, Margin of Symic Bio, Inc. (US)
Table TheraVasc Inc. (US) Information
Table Peripheral Arterial Disease (PAD) Drugs Sales, Cost, Margin of TheraVasc Inc. (US)

LIST OF FIGURES

Figure Global Peripheral Arterial Disease (PAD) Drugs Market Share by Type in 2018
Figure Global Peripheral Arterial Disease (PAD) Drugs Market Share by Application in 2018
Figure Global Peripheral Arterial Disease (PAD) Drugs Market Share by Region in 2018
Figure North America Peripheral Arterial Disease (PAD) Drugs Market Share by Region in 2018
Figure Global Peripheral Arterial Disease (PAD) Drugs Market Share by Region in 2017 (Million USD)
Figure Global Peripheral Arterial Disease (PAD) Drugs Market Share by Region in 2017 (Volume)
Figure Global Peripheral Arterial Disease (PAD) Drugs Market Share by Company in 2017 (Million USD)
Figure Global Peripheral Arterial Disease (PAD) Drugs Market Share by Company in 2017 (Volume)
Figure Global Peripheral Arterial Disease (PAD) Drugs Market Share by Type in 2017 (Million USD)
Figure Global Peripheral Arterial Disease (PAD) Drugs Market Share by Type in 2017 (Volume)
Figure Global Peripheral Arterial Disease (PAD) Drugs Market Share by Application in 2017 (Million USD)
Figure Global Peripheral Arterial Disease (PAD) Drugs Market Share by Application in 2017 (Volume)
Figure Global Peripheral Arterial Disease (PAD) Drugs Market Forecast, 2018-2023 (Million USD)
Figure Global Peripheral Arterial Disease (PAD) Drugs Market Forecast, 2018-2023 (Volume)
Figure North America Peripheral Arterial Disease (PAD) Drugs Market Share by Region in 2017 (Million USD)
Figure North America Peripheral Arterial Disease (PAD) Drugs Market Share by Region in 2017 (Volume)
Figure North America Peripheral Arterial Disease (PAD) Drugs Market Share by Company in 2017 (Million USD)
Figure North America Peripheral Arterial Disease (PAD) Drugs Market Share by Company in 2017 (Volume)
Figure North America Peripheral Arterial Disease (PAD) Drugs Market Share by Type in 2017 (Million USD)
Figure North America Peripheral Arterial Disease (PAD) Drugs Market Share by Type in 2017 (Volume)
Figure North America Peripheral Arterial Disease (PAD) Drugs Market Share by Application in 2017 (Million USD)
Figure North America Peripheral Arterial Disease (PAD) Drugs Market Share by Application in 2017 (Volume)
Figure North America Peripheral Arterial Disease (PAD) Drugs Market Forecast, 2018-2023 (Million USD)
Figure North America Peripheral Arterial Disease (PAD) Drugs Market Forecast, 2018-2023 (Volume)
Figure United States Peripheral Arterial Disease (PAD) Drugs Market Share by Type in 2017 (Million USD)
Figure United States Peripheral Arterial Disease (PAD) Drugs Market Share by Type in 2017 (Volume)
Figure United States Peripheral Arterial Disease (PAD) Drugs Market Share by Application in 2017 (Million USD)
Figure United States Peripheral Arterial Disease (PAD) Drugs Market Share by Application in 2017 (Volume)
Figure United States Peripheral Arterial Disease (PAD) Drugs Market Forecast, 2018-2023 (Million USD)
Figure United States Peripheral Arterial Disease (PAD) Drugs Market Forecast, 2018-2023 (Volume)
Figure Canada Peripheral Arterial Disease (PAD) Drugs Market Share by Type in 2017 (Million USD)
Figure Canada Peripheral Arterial Disease (PAD) Drugs Market Share by Type in 2017 (Volume)
Figure Canada Peripheral Arterial Disease (PAD) Drugs Market Share by Application in 2017 (Million USD)
Figure Canada Peripheral Arterial Disease (PAD) Drugs Market Share by Application in 2017 (Volume)
Figure Canada Peripheral Arterial Disease (PAD) Drugs Market Forecast, 2018-2023 (Million USD)
Figure Canada Peripheral Arterial Disease (PAD) Drugs Market Forecast, 2018-2023 (Volume)
Figure Mexico Peripheral Arterial Disease (PAD) Drugs Market Share by Type in 2017 (Million USD)
Figure Mexico Peripheral Arterial Disease (PAD) Drugs Market Share by Type in 2017 (Volume)
Figure Mexico Peripheral Arterial Disease (PAD) Drugs Market Share by Application in 2017 (Million USD)
Figure Mexico Peripheral Arterial Disease (PAD) Drugs Market Share by Application in 2017 (Volume)
Figure Mexico Peripheral Arterial Disease (PAD) Drugs Market Forecast, 2018-2023 (Million USD)
Figure Mexico Peripheral Arterial Disease (PAD) Drugs Market Forecast, 2018-2023 (Volume)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories